Design Therapeutics (DSGN) Interest & Investment Income (2021 - 2026)

Design Therapeutics (DSGN) has 6 years of Interest & Investment Income data on file, last reported at $2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Interest & Investment Income fell 23.42% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $9.0 million (down 25.9% YoY), and the FY2025 full-year result was $9.7 million, down 24.38% from the prior year.
• Interest & Investment Income eased to $2.1 million in Q1 2026, from $2.2 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $9.3 million in Q4 2023 to a low of -$1.5 million in Q3 2022.
• A 5-year average of $1.9 million and a median of $2.2 million in 2025 frame the typical range for Interest & Investment Income.
• Across the five-year window, Interest & Investment Income slumped 19425.0% in 2022 and surged 18155.56% in 2024, its largest moves.
• Tracing DSGN's Interest & Investment Income over 5 years: stood at $505000.0 in 2022, then soared by 1732.67% to $9.3 million in 2023, then sank by 67.12% to $3.0 million in 2024, then declined by 28.62% to $2.2 million in 2025, then decreased by 4.7% to $2.1 million in 2026.
• Business Quant data shows DSGN's Interest & Investment Income at $2.1 million in Q1 2026, $2.2 million in Q4 2025, and $2.3 million in Q3 2025.